Strawberry Fields REIT (NYSE American: STRW) is a self-administered real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing and other healthcare-related properties. Initially spun out in 2015 with a 33-property portfolio in Indiana and Illinois, the company has steadily expanded its footprint and now owns and leases across 10 states. […]

Public markets have started to embrace sports franchises and related companies in a way rarely seen before. While historically only a handful of clubs and sports organizations went public, the trend has gained momentum, with sports-related stocks across multiple categories delivering strong gains in recent years, according to a Profluence analysis (https://ibn.fm/5IU6R). Brera Holdings (NASDAQ: […]

GlobalTech (OTC: GLTK) is a U.S.-based technology holding company at the forefront of innovation, specializing in artificial intelligence (“AI”), big data and digital infrastructure. With a mission to empower visionary companies and innovation-led enterprises, GlobalTech focuses on enabling growth through strategic partnerships and technology integration. Founded to leverage the opportunities of the fourth industrial revolution, […]

Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration […]

Global demand for energy is picking up, in part due to rising power demand fueled by new technologies like AI and EVs. Now, investors can learn new ways to profit at the MoneyShow Virtual Expo, scheduled for Sept. 9-10, 2025. Attendees at the online event will get tips and recommendations across the natural gas, crude […]

The Pre-Commercial Challenge: Educating Markets on Breakthrough Technology Medical device companies developing breakthrough technologies face a fundamental commercialization challenge beyond regulatory approval: market education. When innovations represent genuine advances over existing standards of care, successful adoption requires comprehensive stakeholder education across patients, clinicians, and healthcare administrators. Izotropic (CSE: IZO) (OTCQB: IZOZF) launched BreastCT.com as a […]

The neural interface revolution is unfolding differently than most technological observers anticipated. While industry attention focused on brain-computer interfaces requiring surgical implants or complex headsets, the real breakthrough is happening at the wrist. Companies are discovering that sophisticated neural signal processing can decode human intent through subtle muscle movements and bioelectric patterns, creating seamless control […]

With a focus on high-grade copper, zinc, lead, gold and silver, Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is not only exploring and developing critical metal resources but also championing responsible, sustainable mining practices that balance economic growth with environmental stewardship. The company is boldly advancing one of North America’s most promising mineral districts: the […]

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, is accelerating its push into the U.S. corrections market. The company announced a second contract in Alabama last week, extending its operations in a state it only entered earlier this year. The news follows last month’s agreement in Tennessee, which marked SuperCom’s […]

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to its intravenous ketamine formulation, NRX-100, for the treatment of suicidal ideation in patients with depression, including bipolar depression (https://ibn.fm/LYPf7). The new designation expands NRX-100’s potential patient population by tenfold compared to the […]